Successful Treatment of Acanthamoeba Infection
Author Information
Author(s): Aichelburg Alexander C., Walochnik Julia, Assadian Ojan, Prosch Helmut, Steuer Andrea, Perneczky Gedeon, Visvesvara Govinda S., Aspöck Horst, Vetter Norbert
Primary Institution: Otto Wagner Hospital, Vienna, Austria
Hypothesis
Can miltefosine effectively treat disseminated Acanthamoeba sp. infection in an immunocompromised patient?
Conclusion
The patient showed significant improvement and remained infection-free for two years after treatment with miltefosine.
Supporting Evidence
- The patient had severe immunosuppression and was co-infected with tuberculosis.
- Miltefosine was effective in treating the skin lesions and brain abscesses.
- Two years after treatment, the patient showed no signs of infection.
Takeaway
A man with a rare brain infection got better after taking a special medicine called miltefosine, and he hasn't been sick for two years.
Methodology
The patient was treated with miltefosine and a combination of other medications, including a standard tuberculostatic regimen.
Potential Biases
Potential bias due to the lack of a control group and reliance on case reports for treatment decisions.
Limitations
The study is based on a single case, limiting generalizability.
Participant Demographics
A 25-year-old immunocompromised male from India living in Austria.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website